REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 38 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $40,000 | +21.2% | 78,108 | -40.7% | 0.00% | – |
| Q2 2016 | $33,000 | +450.0% | 131,620 | +688.2% | 0.00% | – |
| Q4 2015 | $6,000 | -70.0% | 16,699 | -56.3% | 0.00% | – |
| Q3 2015 | $20,000 | +5.3% | 38,176 | +20.1% | 0.00% | – |
| Q2 2015 | $19,000 | +90.0% | 31,797 | +112.8% | 0.00% | – |
| Q4 2014 | $10,000 | -61.5% | 14,941 | -52.9% | 0.00% | – |
| Q3 2014 | $26,000 | -60.0% | 31,689 | -57.4% | 0.00% | – |
| Q2 2014 | $65,000 | +242.1% | 74,378 | +76.5% | 0.00% | – |
| Q3 2013 | $19,000 | +46.2% | 42,132 | +45.4% | 0.00% | – |
| Q2 2013 | $13,000 | – | 28,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |